Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
05 04 2019
Historique:
received: 14 09 2018
accepted: 27 03 2019
entrez: 7 4 2019
pubmed: 7 4 2019
medline: 10 5 2020
Statut: epublish

Résumé

Little is known about salt taste dysfunction among hemodialysis (HD) patients. This study aimed to elucidate the prevalence of salt taste dysfunction and its relationship with interdialytic weight gain (IDWG) among HD patients. A single-center cross-sectional study involving 99 maintenance HD patients was conducted in September 2015. Salt taste threshold was measured using a salt-impregnated test strip. Salt taste dysfunction was defined as a recognition threshold of ≥0.8%. IDWG was calculated as the mean value of weight gain at the beginning of each week during a 1-month period before the taste test. We performed a multivariate analysis using the standard linear regression model to investigate the association between salt taste dysfunction and IDWG. Among the 99 participants, 42% had a recognition threshold of 0.6%, whereas 38% had a recognition threshold of ≥1.6%. Overall, the prevalence of salt taste dysfunction was 58%. The mean (±SD) IDWG was 4.9% (±1.7%), and there was no significant difference in IDWG between the two groups with (4.9%) and without (4.8%) salt taste dysfunction (P = 0.90). A multivariate analysis indicated that salt taste dysfunction is not significantly associated with IDWG (mean difference = 0.06; 95% confidence interval = - 0.27 to 0.40). The prevalence of salt taste dysfunction was very high among HD patients who had a unique distribution of salt taste recognition thresholds with two peaks. We found no significant association between salt taste dysfunction and IDWG.

Sections du résumé

BACKGROUND
Little is known about salt taste dysfunction among hemodialysis (HD) patients. This study aimed to elucidate the prevalence of salt taste dysfunction and its relationship with interdialytic weight gain (IDWG) among HD patients.
METHODS
A single-center cross-sectional study involving 99 maintenance HD patients was conducted in September 2015. Salt taste threshold was measured using a salt-impregnated test strip. Salt taste dysfunction was defined as a recognition threshold of ≥0.8%. IDWG was calculated as the mean value of weight gain at the beginning of each week during a 1-month period before the taste test. We performed a multivariate analysis using the standard linear regression model to investigate the association between salt taste dysfunction and IDWG.
RESULTS
Among the 99 participants, 42% had a recognition threshold of 0.6%, whereas 38% had a recognition threshold of ≥1.6%. Overall, the prevalence of salt taste dysfunction was 58%. The mean (±SD) IDWG was 4.9% (±1.7%), and there was no significant difference in IDWG between the two groups with (4.9%) and without (4.8%) salt taste dysfunction (P = 0.90). A multivariate analysis indicated that salt taste dysfunction is not significantly associated with IDWG (mean difference = 0.06; 95% confidence interval = - 0.27 to 0.40).
CONCLUSIONS
The prevalence of salt taste dysfunction was very high among HD patients who had a unique distribution of salt taste recognition thresholds with two peaks. We found no significant association between salt taste dysfunction and IDWG.

Identifiants

pubmed: 30953463
doi: 10.1186/s12882-019-1312-3
pii: 10.1186/s12882-019-1312-3
pmc: PMC6451217
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

121

Subventions

Organisme : the Institute for Health Outcomes and Process Evaluation research (www.i-hope.jp)
ID : KJ14-02
Pays : International

Références

Nephrol Dial Transplant. 2013 Apr;28(4):797-802
pubmed: 23129821
Kidney Int. 2012 Jul;82(2):204-11
pubmed: 22418981
Nephrol Dial Transplant. 2000 Dec;15(12):2063
pubmed: 11096160
J Am Diet Assoc. 1984 Oct;84(10):1203-6, 1209
pubmed: 6481044
Acta Otorhinolaryngol Belg. 1985;39(5):822-31
pubmed: 4096222
Nephron. 1980;26(4):163-70
pubmed: 7432578
Kidney Int. 1979 Jan;15(1):49-53
pubmed: 491397
J Ren Nutr. 2013 Jul;23(4):288-295.e1
pubmed: 23046735
J Ren Nutr. 2002 Jan;12(1):38-41
pubmed: 11823992
Nephrol Dial Transplant. 2009 Mar;24(3):956-62
pubmed: 19004849
Kidney Int. 2009 Sep;76(6):638-43
pubmed: 19516246
J Nutr. 1999 Jan;129(1):122-5
pubmed: 9915887
Am J Kidney Dis. 1998 Jul;32(1):139-45
pubmed: 9669435
Clin Nephrol. 1996 Mar;45(3):169-74
pubmed: 8706357
ORL J Otorhinolaryngol Relat Spec. 1996 Sep-Oct;58(5):258-61
pubmed: 8936475
Semin Dial. 2010 Jul-Aug;23(4):415-21
pubmed: 20557489
Eur J Med. 1992 Jul-Aug;1(4):208-14
pubmed: 1341446
Pharmacol Biochem Behav. 1984 Aug;21(2):203-8
pubmed: 6483932
Am J Clin Nutr. 1980 Jul;33(7):1517-21
pubmed: 6772011
Circulation. 2009 Feb 10;119(5):671-9
pubmed: 19171851
JAMA. 1997 Oct 22-29;278(16):1357-62
pubmed: 9343468
Appetite. 1992 Apr;18(2):111-9
pubmed: 1610160

Auteurs

Mai Tanaka (M)

Department of Nephrology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan. mai-0503@koto.kpu-m.ac.jp.

Hiroki Nishiwaki (H)

Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Hiroshi Kado (H)

Department of Nephrology, Omihachiman Community Medical Center, Omihachiman, Shiga, Japan.

Yohei Doi (Y)

Department of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.

Chieko Ihoriya (C)

Department of General Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan.

Kenji Omae (K)

Department of Innovative Research and Education for Clinicians and Trainees, Fukushima Medical University, Fukushima, Japan.

Keiichi Tamagaki (K)

Department of Nephrology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH